ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

121
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
Refresh
bearishFast Retailing
12 Feb 2018 08:14

Trading the BOJ-Nikkei 225 Baskets

One week ago in The BOJ's Ongoing ETF Impact - Is a Nikkei 225 Reshuffle in the Cards? I discussed the BOJ's past and current ETF purchasing...

Logo
459 Views
Share
bearishFast Retailing
04 Feb 2018 14:29

The BOJ's Ongoing ETF Impact - Is a Nikkei 225 Reshuffle in the Cards?

Just over six months ago, a breathless article on Bloomberg noted that according to their calculations, the BOJ owned 71% of the ETFs in the...

Logo
1.6k Views
Share
bullishCelltrion Inc
04 Feb 2018 00:10

Last Week in Event SPACE - Astellas, Celltrion, Renesas, AWE, Viva, Kushikatsu

Last week, Astellas Pharma Inc (4503 JP)'s latest buyback may impact the stock; KOSDAQ 150 names expected to benefit as Celltrion Inc (068270 KS)...

Logo
195 Views
Share
bullishAstellas Pharma
31 Jan 2018 19:45

Astellas (4503 JP) Buyback - How It Stacks Up Against Past Buybacks

A small note about the buyback. There is more here than meets the eye.Today, Astellas Pharma Inc (4503 JP)announced a buyback program to repurchase...

Logo
197 Views
Share
03 Nov 2017 08:49

Industrial Capsule: Pharmaceuticals in Japan

Industry’s growth facilitated by healthcare spending as Japan’s society agesThe revenue of Japanese pharmaceutical producers continued to grow in...

Share
x